Track recurring approval, licensing, and rule-change catalysts across regulatory markets.
Next catalyst: Regulatory Approvals & Licensing · July 23, 2026 · July 23, 2026 at 12:00 AM
Compare-ready catalysts
0
These upcoming catalyst instances already carry approved cross-source linkage, so compare/alignment value remains available inside the recurring family.
Source footprint
4
The recurring family inherits the source footprint of its linked catalysts rather than inventing a separate data model.
Recurring cadence
Scheduled
Cadence stays descriptive and lightweight in v1 so recurring research surfaces remain easy to reason about.
This recurring layer stays conservative: a catalyst only joins this family when its title or linked-market family clearly matches these signals.
The recurring family inherits the source footprint of its linked catalysts rather than inventing a separate data model.
These upcoming catalyst instances reuse the current catalyst layer and preview the linked prediction markets directly on the page.
Linked markets
FDA approves Sanofi's Subcutaneous Sarclisa?
FDA approves Elevar Therapeutics' Rivoceranib + camrelizumab?
Linked markets
FDA decision: Gedatolisib by Celcuity Inc. (July 2026)
Will the FCC pull a Big Four TV station license?
FISA Section 702 reauthorized by…?
Linked markets
FDA approves a psychedelic for medical use in 2026?
Who will Trump announce as next FDA commissioner?
FDA approves Retatrutide this year?
Linked markets
When will it first be possible to rent an autonomous vehicle to drive between cities in North America without a license?
US grants license for new nuclear reactor before 2027?
FDA decision: Iberdomide by Celgene (in 2026)
Linked markets
Will the FDA approve retatrutide?
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
Recent instances stay visible here when the current data still supports them, so the recurring family has context beyond the next catalyst.
Linked markets
How many of the DoE Reactor Pilot Program projects will achieve criticality by 2026-07-04?
Which DoE Reactor Pilot Program reactors will achieve criticality by 2026-07-04?
Linked markets
FDA decision: Cytisinicline by Achieve Life Sciences (June 2026)
FDA decision: Roflumilast (ARQ-151) by Arcutis Biotherapeutics (June 2026)
Will the FDA approve cytisinicline for smoking cessation?
Linked markets
FDA approves Viridian Therapeutics' Veligrotug?
FDA approves Ionis' Olezarsen?
Binance receives MiCA license by June 30, 2026?
Linked markets
FDA approves Unicycive's Oxylanthanum carbonate?
FDA approves Arcutis' Zoryve cream?
Linked markets
FDA approves Merck's Welireg + Keytruda or Keytruda Qlex?
FDA approves Arcalyst technology transfer?
FISA Section 702 reauthorization by EOY 2026?
Linked markets
College Baseball: SEC Tournament Champion
Marty Makary out as FDA commissioner?
Will the FDA approve baxdrostat for hard-to-control hypertension?